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Title: Footwear and insole design features for offloading the diabetic at risk foot - A Systematic 
Review and Meta-Analyses 
The aim of this systematic review is to identify the best footwear and insole design features for 
offloading the plantar surface of the foot to prevent foot ulceration in people with diabetic 
peripheral neuropathy. We searched multiple databases for published and unpublished studies 
reporting offloading footwear and insoles for people with diabetic neuropathy and non-ulcerated 
feet.  Primary outcome was foot ulcer incidence; other outcome measures considered were any 
standardised kinetic or kinematic measure indicating loading or offloading the plantar foot.  Fifty-
four studies, including randomized controlled studies, cohort studies, case-series, and a case-
controlled and cross-sectional study were included. Three meta‐analyses were conducted and 
random effects modelling found peak plantar pressure reduction of arch profile (37 kPa (MD, -37.5; 
95% CI, -72.29 to -3.61; p < 0.03), metatarsal addition (35.96 kPa (MD, -35.96; 95% CI, -57.33 to -
14.60; p < 0.001) and pressure informed design 75.4kPa (MD, -75.4kPa; 95% CI, -127.4kPa to -23.44 
kPa; p < 0.004).The remaining data were presented in a narrative form due to heterogeneity. This 
review highlights the difficulty in differentiating the effect of different insole and footwear features 
in offloading the neuropathic diabetic foot. However, arch profiles, metatarsal additions and 
apertures are effective in reducing plantar pressure. The use of pressure analysis to enhance the 










Foot ulceration is amongst the most serious complications of diabetes mellitus 1. It is expected that 
19-34% of people with diabetes will develop a foot ulcer at some point 2. Foot ulceration is known to 
precede 80% of all diabetic lower limb amputations 3,4.  A longitudinal study of a diabetic community 
reported new ulcer incidence as an estimated 2% annually 5 whilst other studies have noted ulcer re-
occurrence rates of 30-40% in the first year after an ulcer episode 2,6,7. Prevention of foot ulceration 
occurrence and reoccurrence are now recognised as key strategies in reducing the concomitant 
burden to patients with diabetes and the healthcare system 8. 
 
The cause of diabetic foot ulceration is multifactorial 9.  However, reducing high plantar loads or foot 
pressures is one mechanism by which foot ulceration may be prevented 10. Elevated dynamic plantar 
pressures during locomotion contribute to the development of plantar diabetic foot ulcers when in 
the presence of neuropathy 11,12. Guidelines recommended that people with diabetes wear 
appropriate ‘diabetic footwear’ designed to reduce repetitive stresses at all times 13. Systematic 
reviews have demonstrated the effectiveness of footwear and insoles in offloading the plantar load 
under the foot and preventing ulceration 14-18.  However, these have not identified the best insole 
design or feature and footwear specification or modification for use when reducing plantar load for 
foot ulcer prevention in people with diabetes and neuropathy.  
 
Therefore the purpose of this systematic literature review is to identify the best footwear and insole 
design features for offloading the plantar surface of the foot to prevent foot ulceration in people 
with diabetes.  It is anticipated that this information will inform a standardised protocol for the 
clinical design of therapeutic insoles and footwear to offload the foot and reduce ulcer risk in people 
with diabetes and neuropathy. 
 
More specifically, the objectives are to identify the key design features with regard to: 
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 profile/shape of the insole, shoe upper and shoe outsole 
 material type and properties of the insole and shoe outsole 
 modifications made to the insole and shoe outsole 
 fabrication techniques used for the insole and shoe 
 
METHODS 
This systematic review was performed and reported according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) Guidance 19.  The systematic review was 
prospectively registered on the PROSPERO database for systematic reviews (CRD42017072816). 
 
The population of interest was adults over 18 years of age with type 1 or 2 diabetes mellitus and 
peripheral neuropathy.  The primary outcome was foot ulcer incidence; other outcome measures 
considered were any standardised kinetic or kinematic measure indicating loading or offloading the 
plantar foot (such as plantar pressure, pressure-time integral, total contact area, dynamic measures 
of centre of pressure trajectory or velocity) and any standardised clinical measure indicating 
loading/offloading of the plantar foot (such as callus/lesion reduction). Side effects/adverse events 
as a result of the design features were additional outcomes of interest. We excluded studies on 
people with active ulceration, major amputation of the foot or Charcot arthropathy because we 
considered that the unique patho-mechanics and gross deformity associated with the severity of 
these conditions would unduly influence the design features of the footwear and insoles.  
 
This review included both experimental and epidemiological study designs including randomised 
controlled trials, non-randomised controlled trials, quasi-experimental, before and after studies, 
prospective and retrospective cohort studies and analytical cross-sectional studies. Studies were 
included if they made one of the following comparisons: Footwear and/or insole design feature 
compared to another therapeutic footwear and/or insole design feature; footwear and/or insole 
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design feature compared to no intervention.  Qualitative studies, case reports and systematic 
reviews were excluded.  
 
The initial literature search was performed on 27 July 2016 by one researcher (RC) and covered 
publications in English and was not restricted by date.  The search was updated on 27 December 
2017 and 30th October 2019. The following databases were searched:  Excerpta Medica Database 
(EMBASE) via Ovid, Medline and Cochrane Database of Systematic Reviews, AMED (EBSCO), 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), MEDLINE, Joanna Briggs Institute 
Database of Systematic Reviews, and PROSPERO.  A search for unpublished studies was undertaken 
in EThOS, Pearl, Web of Science, Google Scholar, SIGLE.  The search strings were prepared with the 
help of an evidence synthesis specialist. An example of the search from one of the databases is 
provided in Electronic Supplement Material 1. Title and abstract of all papers retrieved by the 
literature search were screened independently by two researchers (RC and JP) to determine whether 
the paper met the inclusion criteria with disagreements resolved by discussion. Full text articles 
were then retrieved and further screened by two researchers (RC and JP) independently for inclusion 
in the review. In addition, a hand search was undertaken using the references from journal articles.  
 
RESULTS 
The initial electronic search generated 7384 articles of which 2094 were duplicates (figure 1). In the 
screening phase, 4750 were excluded based on their title and a further 466 excluded on title and 
abstract leaving 74 articles for full text assessment. We excluded 28 of these articles based on 
irrelevant study population (n=12), irrelevant study design (n=4), irrelevant outcome/ intervention 
(n=12) leaving 46 20-65 included in the final review. As the initial search was undertaken in July 2016, 
updated searches were performed in December 2017 yielding 6918 articles, from which an 
additional three studies 66-68 were included and November 2019 yielding 7821 articles from which a 





Data extraction of included studies was conducted using JBI Meta-Analysis of Statistics: Assessment 
and Review Instrument (JBI-MAStARI)74. In this phase, the general and contextual data was extracted 
in relation to the population, study design, interventions (features, design, modifications and 
materials of footwear and insoles) and outcomes. In addition, relevant information was extracted in 
the results section. Data extraction was carried out by (RC) and checked by the second reviewer (JP).  
 
Data analysis and synthesis 
In this review, we summarised study findings quantitatively and pooled study effects in a meta-
analysis when appropriate using JBI MAStARI 74. Meta-analysis was performed using random-effects 
models for continuous variables, calculating mean differences using the inverse variance method. 
Meta-analysis was based on changes from baseline for peak pressure when the mean and SD were 
reported where any footwear or insole design feature, modification, material or method could be 
distinguished. Means and SD’s of data was required to be included in the meta-analysis; we 
contacted four corresponding authors to request this data when not included in the article; two 
authors did not respond and one no longer had access to the data.   
 
For all estimates, we computed the 95% confidence intervals (CI’s). We quantified statistical 
heterogeneity using the I-Squared statistic (I2) and considered heterogeneity as low (<25%), 
moderate (>25% to 50%), or high (>50%) 75, although we did not pre-specify any degree of 
heterogeneity that would preclude meta-analytic pooling.  
 
Assessment of study quality 
Two reviewers (RC and JP) independently assessed the methodological quality of the studies using 
the relevant JBI critical appraisal tools 76. Disagreements were resolved through consensus meeting. 
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A study was considered low risk of bias if all criteria was included. Summaries of the appraisal of 
study quality are included in electronic supplementary material 2. All studies had some form of bias 
with standards of reporting variable across studies and by study design. From the quality assessment 
of the randomised controlled trials (RCT’s, all of the RCT studies had some form of bias (mean 
percentage of ‘yes’ scores = 65% ± s.d.29%).  All RCT studies reported inclusion criteria of 
participants, p values and participants lost to follow up. The most frequent omissions related to the 
blinding of the assessor and participants, concealing of treatment allocation and outcomes 
measurement. Within all of the cohort studies, some form of bias existed (mean percentage of ‘yes’ 
scores = 56% (± s.d. 31%).  The most frequent omissions related to confounding factors, short follow 
up periods and incomplete follow up.  Within the case-controlled studies mean percentage of ‘yes’ 
scores = 70% (± s.d. 0%). Omissions related to confounding factors, lack of sample size justification 
and different criteria used for the identification of cases and controls. For the case series study, 
percentage of ‘yes’ scores = 60%. Omissions related to inclusion criteria, reporting of demographics 
and participants’ characteristics. For the non-randomised cross over study, percentage of ‘yes’ 
scores = 75% with omissions relating to confounding factors and selection bias. 
 
Characteristics of included studies 
Study characteristics are reported in table 1. Fifty-four studies met the inclusion criteria. Study 
designs included: n=13 RCT’s 23,25,31,38,42,49,55,56,61,62,70,73,77, n=37 cohort studies 20-22,24,26-30,32-37,39-41,43,45,47-
49,51-54,57-60,64,66-68,71,72, n=2 case control studies 44,63, n=1 non-intervention case series study 46 and n=1 
non-randomised cross sectional over trial 65. Four authors reported results of the same study in 
different papers 21,22,39,40,45,47,49,50 and therefore results from these studies were described, but only 
one set of each results was used within any meta-analysis. Studies were published between 1975 
and 2019, undertaken in US (n=17) 20,24,33,35,37,42,45-48,51,54,55,58,59,62,65, UK (n=10) 23,30,32,49,50,67,68,71,73,77, 
Netherlands (n=7) 21,22,26,27,36,52,64, Germany (n=4)28,29,44,57, Italy (n=2)56,61, Australia (n=3)25,31,53, Taiwan 
(n=3) 39,40,43, Spain (n=2) 34,70, Thailand (n=2)66,72, Austria (n=1)41, Sweden (n=1)38, Hong Kong (n=1)60, 
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India (n=1)63. The number of participants recruited to treatment groups ranged from seven to 298. 
Twenty-seven studies (50%) recruited participants with diabetes mellitus and peripheral neuropathy 
whilst 19 studies (35%) recruited participants with diabetes mellitus, peripheral neuropathy and 
history of foot ulceration; a further two studies recruited participants with diabetes mellitus and 
peripheral arterial disease; three studies recruited participants with diabetes mellitus and classified 
at high risk of foot ulceration; two studies recruited participants with diabetes mellitus only; two 
studies recruited participants with diabetes mellitus, peripheral neuropathy and high forefoot 
pressures; one study recruited participants with diabetes mellitus, peripheral neuropathy and foot 
deformity; one study recruited participants with diabetes mellitus and foot callus; one study 
recruited participants with diabetes mellitus and taking insulin; one study recruited participants with 
diabetes mellitus and classified at low risk of foot ulceration. Follow up time periods ranged from no 
follow up to five years. 
 
Description of outcome measures 
Twenty percent (n=11) of studies 29,34,42,54-56,58,61,62,70,77 reported foot lesions and ulceration as the 
primary outcome measure. Measurement of this outcome varied across all of the studies, with only 
one study 54 using a validated wound classification system; six studies 34,42,55,62,70,77 used a broad 
definition of ‘lack of skin integrity through loss of the epidermis and dermis’ and the remaining 
studies had no definition of an ulcer or lesion 29,56,58,61. All of these studies used professional 
judgement to assess for the presence of ulceration, although two of the studies 55,62 used 
photographs as a means of blinded assessment. Four percent (n=2) studies 31,59 used the presence of 
callus as the primary outcome measure, one study 31 applied a non-validated grading system to 
assess callus condition, whilst the other 59 measured diameter and thickness of callus lesion. One 
study 57 reported ground reaction force (GRF) and electromyographic (EMG) activity of three muscles 
as outcome measures. One study 65 used temperature (°C) as an outcome measure, inferring a rise in 
temperature with increased risk status when testing the shear reduction device. Seventy two 
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percent (n=39) of studies 20-27,30,32,33,35-41,43-53,57,60,63,64,66-68,71-73 used kinetic outcomes to evaluate the 
effectiveness of the footwear and insole intervention provided. However, there was considerable 
inconsistency in the measures amongst these studies, with mean peak pressure, maximum pressure, 
maximum mean pressure, mean total pressure, pressure time integral and force time integral all 
used.  
 
Profile/shape of the insole, shoe upper and shoe outsole 
Two features of insole profile were described in the majority of studies; arch profile and rocker 
profile. In total, 69% (n=37) of studies20-29,34,36-38,41,43-46,48-51,53-56,58-64,66,68,73 reported using an arch 
profile as a feature of an insole (electronic supplementary material 3) and 37% (n=20) of studies 26,28-
30,34,35,38,40,48-50,52,54-56,61,64,65,67,70 reported rockers as an added feature of the shoe outsole (electronic 
supplementary material 4). One study 39 lacked enough clarity in the description of the intervention 
to determine  if a rocker feature was used in the diabetic footwear. 
 
Only ten percent (n=5) repeated measure studies 21,24,36,43,60 measured the direct effect of an arch 
profile on mean peak pressure. According to the heterogeneity test, high heterogeneity existed 
(I²=81%, 1160 = ²ז ,13.6= ²א, p=0.009). Therefore, random effects modelling was applied to 
consolidate the effect value. Figure 2 shows that that out of 119 participants, the addition of an arch 
profile reduced peak pressure by a mean of 37 kPa (MD, -37.5; 95% CI, -72.29 to -3.61; p < 0.03) 
when compared to a flat insole. For the remaining 31 studies 20,22,23,25-29,34,37,38,41,44-46,48-51,53-56,58,59,61-
64,66,68 who reported using the arch profile as a feature of the insole, meta-analysis was not 







Figure 2 – forest plot of arch profile versus no arch profile 
 
Four studies reported the effect of a rocker profile. One study reported that in 71-81% of 
participants tested an optimum peak pressure target value of under 200kPa could be achieved with 
a combination of apex position at 52% of shoe length and rocker angle of 20° 67. Another study 
reported no interaction effect when altering apex angle, apex position and rocker angle compared to 
the control shoe 30. A third study reported decreases in peak pressures and pressure time integrals in 
the posterior and anterior, central lateral and central medial forefoot with a standardised rocker 
shoe with apex position (83mm on medial and 87mm on lateral from front of shoe), angle thickness 
(24mm maximum thickness at rocker with 11mm rocker height at front end) compared to shoe 
without rocker 40.  A fourth study reported ulcer re-occurrence to be 64% with a semi-rigid rocker 
sole compared to 23% with a rigid rocker sole 70. There was an inability to distinguish the effect of 
the rocker profile feature from other features of the footwear and insole for those remaining studies 
26,28,29,34,35,38,48-50,52,54-56,61,64,65. 
 
Modifications made to the insole and shoe outsole 
 
Sixty-five percent (n=35) of studies 20-22,24,26,31,33,34,37,39,41,43,44,49,50,52-56,58,60-62,65,70 reported modification 
of footwear, although no separation of this feature from others would allow a pooled effect analysis 
to occur (electronic supplementary material 5). Fourteen studies 20-22,24,26,34,37,41,43,52,56,60-62 reported 
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using extra-depth shoes as a modification, five studies used diabetic footwear 31,39,43,49,50 and one 
study 60 reported patient specific footwear, customised to the individual, but did not report the 
effect this had on any outcome measure. 
 
Thirty-three percent (n=18) of studies 21-23,26,27,36-38,45-48,56,62,64,68,71,73 reported the use of metatarsal 
addition to the insole (supplementary material 6). Only three repeated measure studies 21,36,45 could 
distinguish the effect of a metatarsal addition independently from other insole and footwear 
features and were used for the meta-analysis. According to the heterogeneity test, high 
heterogeneity existed (I²=0%, 0 = ²ז ,0.34= ²א, p=0.844). Therefore, random effects modelling was 
applied to consolidate the effect value. Figure 3 shows that out of 70 participants, the use of a 
metatarsal addition in an insole reduced mean peak pressure by a further 35.96 kPa (MD, -35.96; 
95% CI, -57.33 to -14.60; p < 0.001) when compared to an insole without metatarsal addition. There 
was a lack of description of the metatarsal addition and no clear indication of how or when to utilise 
it as a modification.  
 
Figure 3 – forest plot of metatarsal addition compared to insole only 
 
Twenty-two percent (n=12) of studies 21,22,26,27,34,43,48,53,64,68,70,73 modified insoles with the use of a cut 
out or aperture to target the site or lesion under the foot of clinical interest (electronic 
supplementary material 7). However, only two studies 21,43 reported the direct effect of this feature. 
Arts (2015) reported the reduction of in-shoe peak pressure of 21kPa from 253(48) kPa to 232(54) 
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kPa with the removal of material in the insole for a variety of target locations 21; and Lin reported 
reductions of MPP at regions of interest (ROI) located in the forefoot by 72kPa from 221.4(50.3) kPa 
to 149.9(34.8) kPa with the removal of 1cmx1cm² plugs from underneath ROI 43. 
 
Thirteen per cent (n=7) of studies 27,31,33,36,42,73,77 used ‘other’ modifications. One study reported a 
71% reduction on ulcer incidence when using ‘intelligent’ insoles with pressure detecting sensors 
compared to the control group 77. One study reported a 9kPa reduction in mean peak pressure when 
adding a custom made five degree full length varus and valgus cork posts to the base of the insole 
for 20 participants with diabetic peripheral neuropathy and non-deformed feet 36. The remaining 
studies did not report the effect of these modifications. One study reported balancing the ¾ length 
orthotic with the use of dental acrylic posts at the rearfoot 31 and another study used extra-density 
padding at the heel, forefoot and covering the toes as a modification 33. Another study reported the 
use of wedge or medial skive on two occasions, prescribed at the discretion of an orthotist, but no 
rationale for use provided 73. One study reported including elastic binders and two non-stick sheets 
placed between the upper and lower pad of the insole as part of their shear resistant insole 42 and 
one study used substantial heel cups in the design of their insole, although no specification was 
disclosed 27. 
 
Fabrication techniques used for the insole and shoe 
Forty-three  per cent (n=23) of studies 20-22,25-27,31,37,38,45,48-50,54-56,60,61,63,65,66,68,72,73 used casting 
techniques to fabricate the insole and shoe (electronic supplementary material 8) and 20% (n=11) of 
studies 21,26,27,34,36,43,48,54,56,64,73 used kinetic information to inform the fabrication of the insole or shoe 
(electronic supplementary material 9). One study used both a ‘traditional’ foam box casting 
technique and a weight bearing foot scan technique 73. Another study 44 used a pedorthist to prepare 
the insoles individually, although no further information was reported and one study 29 reported the 
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manufacture of the shoe by a local shoemaker according to an algorithm, but did not disclose the 
technique of the insole fabrication. Three studies 23,49,50 used preformed insoles. 
 
Only one repeated measures study 60 reported effects of casting techniques to manufacture insoles 
under different loading conditions. Therefore, pooled analysis was not possible due to the diversity 
of techniques and lack of reported outcomes. Tsung et al 60 reported decreases in MPP compared to 
shoe only condition of 13.4% when casted non-weight bearing, 13.8 % when casted with a semi-
weight bearing insole, 8.1% when casted with a full weight bearing insole, and 2.4% with a flat 
insole.   
  
Twenty per cent (n=11) of studies 21,26,27,34,36,43,48,54,56,64,71 used kinetic analysis to inform the design 
and modification of the insole (electronic supplementary material 9). Only one study 56 used 
ulceration as an outcome measure, the remainder using kinetic measures.  Four repeated measure 
studies 26,43,48,64 reported the direct effect of using plantar based pressure analysis as a fabrication 
technique to inform the design and modification of the insole and shoe in reducing mean peak 
pressure. According to the heterogeneity test, high heterogeneity existed (I²=93%, ²ז ,63.98= ²א = 
2565.09, p=0). Therefore, random effects modelling was applied to consolidate the effect value. 
Figure 4 shows that in 189 participants, MPP in insoles fabricated with the use of an in-shoe system 
was reduced by 75.4kPa (MD, -75.4kPa; 95% CI, -127.4kPa to -23.44 kPa; p < 0.004) compared to 









Figure 4 – forest plot of insoles modified by pressure information versus traditional design insoles 
 
Material type and properties of the insole and shoe outsole 
Sixty-nine percent (n=37) of studies 21-23,25-30,34,36,41-44,46,48-50,52-56,58,60-66,68,70-73 used a combination  of 
materials with diverse properties to manufacture the insoles or shoe outsole (electronic material 
supplementary 10). Thirty per cent (n=16) of studies 20,23,27,29,34,35,46,48-50,52,54,55,58,60-62,68 used dual 
density constructs, thirty-nine percent (n=21) of studies 21,22,25,26,28,30,36,41-44,52,53,56,63-66,70,72,73 used tri or 
multi-density/layers. Five studies examined the influence of material on reducing MPP. One RCT 38 of 
114 DPN participants directly examined the effectiveness of CMI’s constructed of different materials. 
Comparisons of kinetic variables for a 35 shore Ethyl-Vinyl Acetate (EVA) CMI with a 55 shore 
hardness EVA CMI and a prefabricated insole (GloboTec, Comfort 312750501400) all within a 
standardised walking shoe were reported. The main pressure reduction between the CMI and the 
prefabricated insoles was achieved at the heel and in the overall peak pressure of 180kPa with the 
extra soft durometer 35 shore hardness EVA insoles as opposed to 189kPa for the soft 55 shore 
hardness EVA insole. The second study reported no statistical differences in reducing plantar 
pressures when comparing orthoses constructed of a single density material, Plastazote (Zotefoams 
Inc., Walton, KY) with a dual density material, Plastazote and Alliplast (Voltek, Brennia, VA) 46. The 
third repeated measures study reported a significant difference in MPP between different densities 
of poron in walking conditions (p<0.0001) 24 although another study found no difference between 
Poron 96 and Poron 4000 in reducing peak pressure 32.  A fifth study reported the reduction of 
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maximum peak pressure at the forefoot with the addition of a multifoam top cover onto the dual 
density custom made insole of plastazote and microcellular rubber 72. 
 
DISCUSSION 
The aim of this review was to identify the best footwear and insoles design feature for offloading the 
plantar surface of the foot to prevent foot ulceration in people with diabetes. More specifically, the 
objectives were to identify the key design features of footwear and insoles with regard to profile and 
shape, material type and properties, modifications and fabrication techniques. 
 
Heterogeneity was found amongst the profile, modifications, material and fabrication techniques 
used in insoles and footwear design. Footwear and insoles can be viewed as multifaceted 
interventions where several features are frequently incorporated into the design. The studies 
highlighted the lack of a systematic approach to combining these features which makes it difficult to 
distinguish the effectiveness of individual features in offloading plantar foot pressures.   
 
Within the review, we revealed variations in outcome measures, study design and quality. Six 
different outcome measures were used amongst the studies which makes meaningful comparison 
difficult. Identification of specific design features of footwear and insoles related to the primary 
outcome measure of foot ulceration was not possible. This was because all of the studies using foot 
ulceration as the outcome measure employed a combination of footwear and insole design features. 
The follow up time-points at which outcomes were measured varied considerably across studies. The 
methodological quality of the studies was generally poor. Only four studies 21,38,50,73 reported 
adherence to the insoles and footwear with one study excluding participants from analysis where 
there was a lack of substantial wear 73. The inclusion criteria contained participants with diabetes 
who were at different stages of disease progression, further adding to the difficulty in making 
meaningful comparisons between studies. Some studies included people with no sensory 
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neuropathy; some studies included those with sensory neuropathy and no previous foot ulceration 
and some studies included participants with sensory neuropathy and previous foot ulceration. Foot 
complication severity has been shown to be associated with increased plantar foot pressures 10. 
However, this did not appear to influence the footwear or insole feature used.  
 
Profile/shape of the insole, shoe upper and shoe outsole 
Two types of profile features were described in this review; an arch and a rocker. The use of an arch 
profile replicating the contour of the plantar surface of the foot has traditionally been the ‘gold-
standard’ for insole design for reducing pressure in the diabetic neuropathic foot 78. This review 
found that 98% of studies reported using an arch profile as part of the insole configuration, although 
inconsistency exists in the reporting of the specifications. Our meta-analysis provides evidence that 
an arch profile when added to an insole can enhance the offloading effect by a further 37kPa when 
compared to an insole without an arch profile. It is postulated that by increasing contact with the 
plantar surface of the foot, thereby allowing an increased distribution of force over a greater area of 
the foot, plantar foot pressure will be reduced 79.  Our review demonstrated that seven studies 
incorporating an insole with an arch profile reported that an increase in surface contact area values 
correlates with reduced forefoot pressures 20,23,46,49,50,53,60. However, Paton et al.  reported that the 
increase in total contact area observed at issue, reduced by  50% after six months of insole wear, 
whilst pressure reduction  remained constant 49,50. The authors suggest that this could be attributed 
to the dynamic nature of gait and associated pressure reduction may be associated with changes in 
foot function, such as the prevention of foot pronation 80,81.  
 
Nineteen studies modified the rocker profile of the shoe as a method of reducing peak pressure. The 
rigid sole added to the bottom of the shoe is designed to limit the movement at foot joints, 
particularly extension of the metatarsophalangeal joints at the propulsive phase of gait. This 
prevents movement of tissue across the plantar aspect of the foot and alters the forefoot loading 
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pattern, specifically reducing pressure under the metatarsal heads by 30% to 50% 82,83. Our review 
demonstrates the multiplicity of design variables in terms of rocker angle, placement, height and 
material. Preece et al., suggested an optimum design of a rocker, but reported further adjustments 
of rocker angle and position reduced pressure on the forefoot across the participants 67.  Chapman 
et al 30 reported high inter-subject variability for apex position in reducing pressure under the 1st 
MTPJ and hallux regions with no clear optimal position. Some consistency was achieved with 
reducing pressure under the 2nd to 4th MTPJ with an apex position of 50-60% of shoe length.  The use 
of a rocker profile could be beneficial in reducing peak pressure under the diabetic neuropathic foot. 
However, the effectiveness of this feature may correlate with an individualised approach in the 
design of the rocker angle, placement, height and material, although no such design algorithm has 
yet been established. 
 
Modifications 
The purpose of modifications is to further adapt the footwear and insole by additional features.  
Three key modifications of insole and footwear design features were identified from this review; 
extra-depth footwear, metatarsal additions and sinks or apertures. However, the inability to 
distinguish the effect of individual modifications from other insole and design features for the 
majority of studies creates uncertainty on the effectiveness of their usage. Additionally, the 
assortment of each modification with variations in design, materials, placement and fabrication 
made direct comparison extremely difficult. Despite this heterogeneity meta-analyses verified the 
positive effect of metatarsal pad, cut-outs or apertures in reducing forefoot plantar pressures. 
However, the effectiveness in reducing plantar pressure varies considerably with placement of the 
modification. For example, Hastings et al., established a pattern of increases or decreases in MPP 
according to placement of the metatarsal pad proximal or distal to the metatarsal, although only an 
effect on the 2nd metatarsal head was observed 37.  A data driven approach using real time plantar 
pressure feedback, as utilised by 10 studies 21,26,27,34,36,43,48,54,56,64  intimates that the effectiveness of 
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some modifications could be enhanced by more accurate siting using appropriate technology, such 
as real time pressure analysis.  
 
Fabrication techniques used for the insole and shoe 
Two different fabrication techniques for insoles and footwear were identified in this review; casting, 
and kinetic informed.  Casting is traditionally used to capture the geometric shape of the patient’s’ 
foot to ‘customise’ the insole. Only one study examined the role of three types of casting technique 
in reducing peak pressure 60. The authors reported an insole formed from a semi-weight bearing foot 
shape offered the greatest peak pressure reduction compared to full weight bearing and non-weight 
bearing foot shapes, but was not statistically significant. The remaining studies using a casting 
approach were not able to report any difference in reducing pressure using this fabrication method. 
This method of fabrication is believed to create an arch profile, which has been demonstrated as 
altering pressures in the plantar foot as reported by four studies 21,24,36,60.  However, one author, 
Paton et al., 2011, demonstrated no difference in reducing MPP and PTI when using a prefabricated 
insole compared to a customised insole 50. Therefore, potentially all insoles with an arch profile, 
regardless of the casting technique employed, are effective in reducing plantar pressure in people 
with diabetes. This view complements another finding of this review that suggests an arch profile 
may optimise the effect of insoles for diabetic feet.    
 
Ten studies 21,26,27,34,36,43,48,54,56,64 reported the effect of using in-shoe pressure measurement analysis 
to guide the fabrication of the footwear and insole. The use of a data driven approach for insole and 
footwear design has been heralded as authenticating plantar foot pressure reduction on an 
individual basis. Identification of the vulnerable plantar areas with pressure mapping, guides the 
design and alteration of appropriate personalized footwear and insoles in terms of materials, 
geometry and modifications.  In addition, it provides a quantitative assessment of clinical outcome 
such that clinicians can be certain of achieving the desired treatment objective. Our meta-analysis 
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supports this proposition although variations in methodology with this technique requires a more 
consistent approach to limit the inconsistency across clinical areas.  Only one study 54 used pressure 
data to inform the design of the insoles; the remainder used the kinetic data to inform the 
modification of the insoles by iteratively testing and retesting until optimisation was reached. A lack 
of standardisation existed across all of the studies for temporal-spatial measurements and gait 
parameters contributing to the analysis. The use of different pressure analysis systems with 
dissimilar technical specifications and resolution provides additional inconsistency. Furthermore it 
should be acknowledged that foot plantar pressure values are only considered a surrogate measure 
of foot ulceration risk, and that no threshold for foot ulceration has yet been established 84.   
 
Material type and properties of the insole and shoe outsole 
Material choice is an important feature of any insole or footwear design.  The material used, 
dependent on its mechanical and physical properties, will influence the insole or footwear’s ability to 
redistribute or dampen forces effectively. This review found no consistency with individual materials 
used or thickness in the construction of footwear or insole. Only one study directly assessed the 
effect of material hardness in reducing peak plantar pressures 38.  Sixty-seven per cent of remaining 
studies used either dual or multi-density material constructions of footwear and insoles. Closed cell 
foam materials were most frequently sited at the interface between foot and insole and footwear as 
a top cover; denser materials constituted the base of the insole, EVA appearing the most popular 
material of choice for the base. A less popular material type was thermoplastics, potentially because 
these materials were traditionally used for functional devices aimed toward changing gait function 
and not reducing pressure. Combining materials of different properties is suggested as incorporating 
the desired properties from each material to best serve reduction in foot ulceration risk 85-87. 
However the literature does not provide a sufficiently robust evidence base to inform the selection 
approach regarding material combination or thickness for the best offloading. Therefore, selection 
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of materials is often influenced by the availability of materials locally and anecdotal evidence, rather 
than patient specific characteristics and effectiveness of offloading.  
 
LIMITATIONS 
The primary limitation of this review is the heterogeneity of study design and outcome measures of 
the studies included. Large variations in the description of footwear and insoles and uncertainty in 
the reliability and validity of the assessment and intervention methods exists. The diversity of 
features used limits the generalizability of the results, resulting in variation in the number of studies 
and participants included within the meta-analyses. This review was further limited by the inclusion 
of only English language studies, not including trial databases in the search database and exclusion 
of participants with charcot and foot amputation.  
 
RECOMMENDATIONS 
A consensus is required regarding how to report and measure the effectiveness of individual insole 
and footwear features in offloading the DPN foot. A core set of outcome measures and standardized 
time points would facilitate pooling of results in meta-analyses to enable more accurate conclusions 
to be drawn. Standardization of inclusion criteria is further required to ensure all participants 
enrolled in offloading trials of DPN have DPN. This would also include participants with charcot and 
foot ulceration. Improved consistency in the  reporting of methodology, in line with the Consolidated 
Standards of Reporting Trials guidelines and International working group on the diabetic foot, is also 
recommended 84.  
CONCLUSION 
This systematic review highlights the difficulty in differentiating insole and footwear features in 
offloading the neuropathic diabetic foot. The amalgamation of features in insole and footwear 
designs makes consolidation of the body of knowledge difficult for understanding which feature to 
use at which time point.  However, on the basis of this review we conclude that metatarsal 
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additions, apertures and arch profiles are effective in reducing plantar pressure in this population, 
and therefore should be incorporated as footwear and insole features.  Different casting techniques 
and materials also appear effective in reducing pressures, but we are unable to recommend any 
particular technique or type because of insufficient evidence. The use of pressure analysis to 
enhance the effectiveness of the design of footwear and insoles, particularly through modification, is 
recommended, specifically in patients with diabetes and peripheral neuropathy.  
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Figure 1. Flow diagram of study selection in July 2016 and updated in 






























Additional records identified 
through other sources 
total (n =63) 
(Scholar 61)(Ethos 2) 
Records screened by title after duplicates 
removed 
(n = 5290) 
Records screened by title 
and abstract 
(n = 540) 
Records excluded 
(total n =466) 
No full text (n=1) 
Not in English (n=11) 
Non-diabetic pop= (n=41) 
Not relevant study design 
(n=29) 
Not relevant outcome/ 
intervention (n=386) Full-text articles assessed 
for eligibility 
(n =74) 
Full-text articles excluded with 
reasons total (n =28) 
Not relevant study population 
(n=12) 
Not relevant study design (n=4) 




Studies included in 
quantitative synthesis  
(n = 54) 
Records rejected through 
non-relevance 
(n = 4750) 
Updated Dec 2017 
(n=3) 
Updated Nov 2019 
(n=5) 
 
Records identified through 
database searching 
total (n = 7321) 
 (Ebsco 3587) (Ovid 3671) 
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Table 1 – characteristics of studies 
Author/year Study setting Study 
design 





Comparator Follow up 
period 
Outcomes 
Abbott et al, 
77 

















68% ulcer free in control 






n=8 DPN  67 (10.1) Unknown Without 
orthotic 
3 months PPP↓ 30-40% under 1st MTPJ 
& medial heel. 
5-10% ↑Total contact area 











PPP↓23%  at target location; 
PPP↓ 13.5-24% by adding  
metatarsal bar or pad with 
replacement of top-cover 





62.8 (10.2) 140:31 Barefoot Unknown PPP↓ 50-76% (deformed 
feet), 14-66% (non-deformed 
feet) 85% (previous ulcer 
location). 61% Successfully 
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offloading below 200kPa & 
62% at previous ulcer site.  






68:35 3mm cleron 
flat insoles 
6 months With orthoses: (22% MPPP↓, 
16% Pressure time integral↓ 
& 11%↑mean Contact area); 
With insoles (16% ↓MPPP, 
10% Pressure time integral↓ 
& 2%↑ mean Contact area) 










n/a Mean PPP↓55% (wearing 
own CMI & shoe vs without 
insoles). mean PPP↓ 36-39% 
(standard shoe wearing ¼ 
inch medium hardness poron 
vs shoe without orthoses)  
Burns et al, 25 Australia RCT n=61 DM 
with PAD & 








37:24 Sham insole  8 weeks Whole foot Mean PPP↓(18% 
CMI vs 8% sham); Rearfoot 
Mean PP↓(27% CMI vs 4% 
sham); Midfoot Mean PPP↓ 
(7% CMI vs 4% sham); 
Forefoot mean PPP↓(16% 
CMI vs 10% sham)  
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64.4 (11.2) 13:7 0.95cm PPT 
flat insole 
n/a PPP↓16%  & Force time 
integral↓ with CMI vs 8% 
with flat insole at 1st MTPJ 
 
Bus et al, 26 Netherlands Cohort 
study 
n=23 DPN 59.1 (12.6) 17:6 Pre & post 
modification 
 All 35 ROI’s successfully 
optimised with average of 









64 49:43 Without 
footwear 







45% Absolute ulcer risk 
reduction for with shoes in 1st 
year 
Chanteleau 
et al, 29 
Germany Cohort 
study 





Foot lesions =78% pre 
intervention vs 41% post  
Chapman et 
al, 30 




57 (8) 31:17 Control  n/a Variations in apex angle: 14% 
maximum pressure↓(1st 
MTPJ) & pressure↑(heel) vs 
control.  For variations in 
apex position: 39% maximum 
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pressure↓ at 2-4MTPJ vs 
control. 
As rocker angle ↑ there was 




Australia RCT n=20 DM & 











Callus grade improved in 
16/22 callus sites (orthotic 
treatment group); remained 












68 unknown No insole 1 week Mean total pressure: wearing 
insole (0.180kg/cm2/s), no 
insoles (0.210kg/cm2/s). 
Mean pressure redistribution 
Poron 96 (0.198kg/cm2/s), 
Poron 4400    
(0.211 kg/cm2/s); total 





n=50 DM at 
high risk of 
57.6 (34-
78) 
32:18 Old footwear 3 & 6 
months 
Peak force at baseline: socks 
only (6.15 kg cm-2), own socks 





socks & shoes (3.98 kg cm-2). 
Mean PPP at 3 months with 
new socks &  shoes (4.13 kg 







with high risk 
foot factors 
& history of 
ulceration 





Pre orthotic 147 ulcerations; 
post orthotic 22 ulcerations. 
Mean PPP with orthotic 
treatment ↓ 85.2kPa  (left 













37 (13.5) 13:12 Patients own 
tennis or 
oxford shoe 
n/a For DM subjects Mean PPP 
with: own shoe (4.46 kg/cm²),  
Surgical boot (4.89kg/cm²),  
Surgical boot & rocker insole 
(2.50kg/cm²).  For non-
diabetic subjects Mean PPP 
with: own shoe(2.07 kg/cm²), 
surgical boot (2.13kg/cm²), 














unknown 11 varying 
insoles 
n/a In central forefoot Mean 
PPP↓ with: metatarsal dome 
(32 kPa), standard arch 
(17kPa), extra arch support 
(45kPa). At medial forefoot 
Mean PPP↓ with: varus 
wedge (9kPa), metatarsal 
dome (42kPa), standard arch 
(12 kPa), extra arch support 
(38kPa).  At hallux Mean 
PPP↓ with extra arch & varus 






n=20 DPN 57.3 (9.3) 12:8 3 insole 
conditions 
n/a At 2nd MTPJ:  PPP↓ (32%) 
when pad placed between 
6.1 & 10.6mm proximally;  
PPP ↓(16%) when pad 
located 1.8mm distal to 
6.1mm proximally; PPP↓ 
(57% ) when distal part of 
met pad was 10.6mm 
proximal to met head; PPP↑ 
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when pad was further than 
1.8mm distally or >16.8mm 
proximally.  
Hsi et al, 39 Taiwan Cohort 
study 
n=14 DPN 61.4 (8.3) 6:8 Patients’ 
own shoes 
n/a Diabetic footwear: Pressure 
time integral (↓heel), 
(↓anterior to MTPJ), (↓at 
toe regions) (↑at the midfoot 
& posterior to MTPJ)  
PPP: (↓heel), (↓anterior to 
MTPJ), (↓at toe regions), 
(↑midfoot & posterior to 
MTPJ).   
Hsi et al, 40 Taiwan Cohort 
study 
n=10 DPN 63(9) 3:7 Patients’ 
own shoes 
 Rocker sole ↓PPP & pressure 
time integralI in anterior 
lateral, central lateral & 
central medial forefoot & 
prolonged time to PPP in 
posterior forefoot but not 
anterior forefoot. 
Kastenbauer 
et al, 41 
Austria Cohort 
study 
n=13 DM 56(8) 5:8 Leather 
styled Oxford 
shoe 
n/a At great toe PPP ↓ with: cork 
insole & in-depth shoe (16%), 
Adidas shoe(32%); CMI & in-
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depth shoe (33%);  At 1st 
MTPJ PPP ↓ with: cork insole 
& in-depth shoe (27%), 
Adidas shoe(29%); CMI & in-
depth shoe (50%); At 2/3rd 
MTPJ PPP ↓ with: cork insole 
& in-depth shoe (19%), 
Adidas shoe(47%); CMI & in-
depth shoe (48%); 
At heel PPP ↓ with: cork 
insole & in-depth shoe (34%), 
Adidas shoe(34%); CMI & in-
depth shoe (39%). 
























3.5 times odds of developing 
an ulcer;  
3 ulcers developed in shear 
resistant insole group, 10 
ulcers developed in standard 
insole group  
Lin et al, 43 Taiwan Cohort 
study 
n=26 DPN 68 (9) 10:16 Standard 
shoe with 
insole 
n/a For regions of interest: 15.7% 
↓Mean PPP (pre-plug 
removal); 32.3% ↓Mean PPP 
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(post vs post plug removal); 
14.3% ↓Mean PPP (arch 
addition to pre plug removal 
vs post plug removal). For 
Non-regions of interest 8.7% 
↓Mean PPP (pre-plug 
removal vs barefoot); 2.2% 
↑Mean PPP with pre vs post 
plug removal); 2.5% ↓Mean 
PPP (arch addition to pre plug 






n=81 type 2 
DM (n=18 














& 6 & 12 
months  
32.6% ↓Maximum PPP at 
issue 
28% ↓ Maximum PPP at 6 
months; 
13% ↓ Maximum PPP at 12 
months.  
Lopez-Moral 
et al, 70 
Spain RCT N=51DPN 
and previous 
Interventio






6 months Rigid rocker sole ↓ re-










Lott et al, 45 US Cohort 
study 
n=20 DPN & 
history of 
ulceration 
57.3 (9.3) 12:8 Barefoot n/a Mean applied pressure: 
barefoot (272 kPa); shoe (173 
kPa), shoe & CMI (140 kPa); 
CMI & metatarsal pad, (98 
kPa). 
Soft Tissue Strain at 2nd MTPJ: 
barefoot (38.2%), shoe 
(31.6%); shoe & CMI (28.9%); 
shoe, CMI & Metatarsal Pad 
(24.1%).  
Martinez-




n=60 DPN 67(13) 40:20 Flat insole  n/a PPP ↓ of 29KPa with 



















8:8 No insole 1 month 
& 3 
months 
With CMI at baseline: 
decrease in PPP (12.0 N/cm²); 
Max Mean Pressure (4.9 
N/cm²); Pressure Time 





↑Total Contact Area 
(21.2cm²).   
At follow up: decrease in PPP 
(10.5 N/cm²); Maximum 
mean pressure (5.2 N/cm²) & 
Pressure Time Integral (5.9 
N/cm²/s) & ↑ Total Contact 
Area (20.2cm²).  








57(9) 12:8 Shoes with 
standard 
insoles 
n/a 19-24% PPP↓ (CMI), 15-20% 
PPP↓ (CMI +metatarsal pad); 
16-23% Pressure Time 
Integral ↓ (with CMI), 22-
32% Pressure Time Integral↓ 






n=16 DPN 58(9) 9:7 Without CMI n/a PPP↓26% at forefoot and 





N=16 DPN unknown 9:7 Addition of 
multifoam 
top cover 
n/a forefoot maximum PPP 
248.2kPa (61.92) with CMI; 























n/a 168kPa PPP at regions ff 
interest (shape based & 
pressure informed CMI); 
211kPa PP (CMI shape based 
& 45 Shore EVA base with 
Procell or Plastazote top 
cover); 246kPa PPP (CMI 
polypropylene shell with 
Korex, sponge or plastazote 
top cover); In rocker shoes: 
127 kPa PPP at regions of 
interest (shape based & 
pressure informed CMI); 
178kPa PPP ( CMI shape 
based & 45 Shore EVA base 
with Procell or Plastazote top 
cover); 200kPa PP (CMI shape 
based & polypropylene shell 
with Korex, sponge or 
plastazote top cover). 
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Parker et al, 
73 








6 month Compared with control insole 
PPP ↓14.91% with traditional 
insole and ↓24.43% with 
digital insole at baseline 
Paton et al, 
50 










6 months With CMI (37% ↓PPP at 
baseline & 6 months); (27% 
↓Pressure Time Integral at 
baseline & 30% at 6 months); 
(32% ↑Total Contact Area 
baseline & 15% at 6 months). 
With Prefabicated insole: 
(35% ↓PPP at baseline & 
31% at 6 months); (22% 
↓Pressure Time Integral & 
24% at 6 months); (29% 
↑Total Contact Area at 
baseline & 15% at 6 months);   
No difference between CMI & 
prefabricated insole in PPP & 
Total Contact Area  
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↓PPP with CMI of 39% (0 
months), 35% (6 months) & 
36% (12 months)  
Perry et a,l 51 US Cohort 
study 
n=39 total: 
13 DM, 13 










33:6 Sock only n/a Oxford shoes vs socks: 
18% ↓Mean PPP  (2nd MTPJ),  
2.3% ↓Mean PPP (MTPJ’s & 
heel);  
Running shoe vs socks 31% 





n=10 DPN 63 (44-78) 0:10 Oxford shoe 
without 
insole 
n/a 3 Oxford type shoes show no 
significant ↓ in pressure vs 
baseline; 
rocker bottom shoes showed 
~50% ↓PPP  in central 
forefoot vs no rocker;   
mean ↑Total Contact Insole 
with insole (3.4-7.3 cm²) 
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n=102 DM at 
low risk and 
n=66 healthy 
control 
57(9) 52:50 8 shoe 
conditions 
n/a Optimum location of 52% 








61(48-68) 8:0 No insole n/a ↓PPP, Pressure Time 
Integrals & ↑Total Contact 
Area   




n=24 DPN no 
history of 
ulceration 




0 breaks in skin at 6 months 
Reiber et al, 
55 




62 309:91 Usual 
footwear 
2 years Number of feet ulcerated 
15% (shoes & cork insoles), 
14% (shoes & prefabs), 17% 
(control group) 
Rizzo et al,  56 Italy RCT n=298 DM at 











& 5 years 
Foot ulceration development: 
At 12 months 13% 
(intervention) vs 38.6% 
(standard care). 
At year 3, 18% (intervention) 
vs 61% (standard care);  At 
year 5, 24% (intervention) vs 
72% (standard care)  
39 
 











unknown barefoot n/a 1st Ground Reaction Force 
peak >  during shod 
conditions & >  propulsion 
force in diabetic group but 
2nd Ground Reaction Force 
peak  <  in shod diabetic vs 
control group 





38(28-59)  3:4 n/a 10 weeks 6 patients discontinued use 
of footwear (5 plantar 
irritation of heel & 1 
hypertrophic lesions under 
4/5th MTPJ’s) 





55(19-55) 33:45 Own shoes monthly Significant change in callus 
size with running shoes 
Tang et al, 38 Sweden RCT n=114 DPN 
& previous 
ulceration 
58 (15) 62:52 Prefabricated 
insole 
2 years at 
6 monthly 
PPP= 180kPa (35 EVA insole); 
189kPa (55 EVA insole); 
211kPa (prefab) 




n=20 DPN 64.4(9.2) 15:5 Barefoot n/a Optimised milled lowered PP 
by 41.3Kpa compared to CMI 
and optimised printed 
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lowered PPP by 40.5kPa 
compared to CMI. 
Tsung et al, 
60 
Hong Kong Cohort 
study 
n=6 DPN vs 






unknown Shoe-only n/a Mean PPP↓ 13.4% (Non 
Weight Bearing insole),   
13.8 % (Semi Weight Bearing 
insole), 8.1% (Fully Weight 
Bearing insole),   
2.4% (flat insole) 
Uccioli et al, 
61 












Ulcer relapse 58.3% (control) 
vs 27.7% (intervention) 
Ulbrecht et 
al, 62 
US RCT n=150 DPN 
recently 









15 month Ulcer occurrence control> 
insole; no difference in non-
ulcerated lesion. 
Viswanathan 












9 months PPP↓  57% (MCR insole); 
61% (Polyurethane); 58% 






















PPP↓ 23%  (ulcer site) & 21% 
(highest PPP site) 










65.1 14:13 Standard 
control 
insoles 
n/a ↓Temperature of 64.1%  
(forefoot) & 48% (midfoot) 
with DFO  
         
         
US-United States, UK –United Kingdom, DPN – diabetic peripheral neuropathy, DM – diabetes Mellitus,  ↓-decrease, ↑increase, n/a – not applicable, 
CMI- Custom made insole, PPP-peak plantar pressure, MTPJ – metatarsal phalangeal joints 
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Electronic supplement material 1 – example of search string  
"(((diabet*).ti,ab OR (diabetes mellitus).ti,ab) AND ((foot).ti,ab OR (feet).ti,ab OR 
(neuropath*).ti,ab OR (ulcer*).ti,ab OR (pressure).ti,ab OR (gait).ti,ab OR 
(walking).ti,ab)) AND ((time).ti,ab OR (offload*).ti,ab OR (off-load*).ti,ab OR 
(insole*).ti,ab OR (orthos*).ti,ab OR (orthotic devices).ti,ab OR (therapeutic 
footwear).ti,ab OR (shoes).ti,ab OR (shoe inserts).ti,ab OR (footwear).ti,ab OR 
(footwear intervention*).ti,ab OR (footwear adaption*).ti,ab OR (padding).ti,ab OR 
(plug*).ti,ab OR (ankle foot orthos*).ti,ab OR (offloading device*).ti,ab OR (rocker 
bottom).ti,ab OR (rocker sole*).ti,ab OR (flange*).ti,ab OR (arch profile).ti,ab OR 
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Waaijman et 
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Viswanathan et 
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Electronic supplementary material 3 – profile of insole   
Profile of 
insole 









Birke et al, 199924 
 
Non moulded 
insoles of different 
density materials in 
extra depth shoe  
No specifications reported for 
non-moulded or CMI 









techniques to create 
digital image for 
CMI to individualise 
profile 
Standardised adjustment 
technique in manufacture 






Arts et al, 2015 
Arts et al, 
201221,22 
 
Used as part of 
custom made 
feature to modify 
footwear 
Static/dynamic impressions in 
foam box to individualise profile; 
modified using pressure data with 






Paton et al, 2014; 




insoles with medial 
longitudinal arch 
profile 
CMI individualised with 
prescription protocol for foot 
deformity; prefabricated profile 





Lott et al, 2007 
45  
Barefoot, shoe and 
CMI with metatarsal 
pad addition 
conditions 
No insole prescription or 
manufacture reported, no 





Fernandez et al, 
201334 




Foam box impression with 
pathology dependent prescription 
profile - for bony prominences a 
poron longitudinal inner arch 







Reiber et al, 1997; 
Reiber et al, 
200254,55 
Usual footwear Used as one component in 
conjunction with specialist shoe  
plantar foot scanned to create 
individual profile; fitted to patient 
with modifications, no other 





Rizzo et al, 201256  Standard treatment Foam box, static impression to 










Shaped by cast but no 










Proximally located medial arch 
within shoe to tip the heel into a 
varus position, location based on 





Albert  & Rinoie 
199420  
Without orthotic Rigid device from plaster of paris 





Burns et al, 
200925 
Flat insoles Use of plaster casts to 
individualise arch for CMI; no 









Moulded base to individualise 
profile, modifications decided by 
clinician; no specification of 
profile or location of rocker 
CMI with 
medial 
Bus et al, 200427  Flat insole Cad-cam, tracings of feet and 
pressure data to individualise 





profile plus heel cups (no direct 
specifications) with other 
modifications  
Total contact 




Hastings et al, 
200737  
TCI distal metatarsal 
pad, TCI proximal 
metatarsal pad 
Foam box impression to 
individualise profile, no other 





Tang et al, 201438  Prefabricated 
insoles with medial 
longitudinal arch 
Moulds to individualise to profile, 





Kastenbauer et al, 
199841  
Barefoot, Oxford-
style shoe, original 
cork insole  
Customised orthopaedic diabetic 
insole, no prescription, 











No specification of manufacturing 










Foam box  to individualise profile, 
modified according to a static 









Foam box to individualise profile 





Telfer et al, 
201768  
Shape based arch 
profile 
Foam box to individualise profile 
but manufactured using shape, 









No CMI Positive mould cast to individuals 





Waajiman et al, 
201264  
Used as part of 
custom made 
feature to modify 
footwear 
Mould or cast of foot to 






Group not provided 
with footwear and 
insole 
Flat profile to fit inside 
therapeutic shoe 
Unsure Perry et al, 199551 Oxford style shoe 
with no insole 
Reported insole inside running 
shoe but no description of profile 
Pre-fabricated 
insole  
Barnett 200223 Flat insole Non-bespoke standardised 
specification of arch dependent 
on shoe size 
Arched insole Chantelau et al, 
199029  
n/a Constructed according to shape of 
the foot and corrected until 
satisfactory, but no specifications  










Foam box and digital scan to 
individualise profile, with 
intervention orthoses modified by 





Parker et al, 2019 
73 
Flat insoles Medial arch profile with 10mm 
heel cup formed by either foam 
box or weight bearing scan. 
Weight bearing insoles templates 
were adjusted by an orthotist, but 
not disclosed if arch was adjusted 
 Unsure Soulier 198659 n/a Running shoe insole with generic 
reasonable structure shoe, no 
specifications of profile 
60 
 
Unsure Lobmann et al, 
200144 
No insole No description or specification of 










modifications of  
profile by reducing 
arch profile by 5mm, 
adding 5mm and 
10mm arch supports 




Lin et al, 201343 Flat insole Latex arch support, placed under 
talus, navicular and base of 1st 
metatarsal, added to insole with 
double sided tape; size chosen to 








Raspovic et al, 
200053 
Without insole 10 insoles of Non cast type – 
adhering pieces of D-shaped pad 
on flat base of medial longitudinal 
arch area; two neutral shell 
insoles. No reporting of 
specifications and positioning of 
pad. 











Electronic supplementary material 4 rocker profile 
Rocker 
modification 
Studies (n=20) Comparator Comments 
Stiff bottom 
rocker with 
early pivot to 
shoe outsole 




Generalised specifications used on 
participants with previous ulceration or 
forefoot amputation, marked 
deformities, hallux amputation and 





bottom to shoe 










Reiber et al, 
1997; 




No specifications of rocker profile 
reported; specified treatment objective 
to generate a smooth rolling motion from 
heel to toe with normal gait to decrease 
range of motion in tarso-metatarsal joints 
and reduce gait induced plantar stress-  
Semi rigid 
rocker to shoe 
outsole 





Developed according to Towey 
guidelines; No further specifications 
reported 
Semi rigid 
rocker to shoe 
outsole 
Wrobel et al, 






No further specifications reported 
Anteroposterior 
rigid rocker to 
shoe outsole 
Lopez-Moral 




20 ° rocker angle between floor and sole 
under metatarsal heads with rigid 
















No specifications reported but aims to 
decrease plantar pressure beneath 
metatarsal heads and prolong pain free 
walking 
EVA micro 
rubber sole on 
therapeutic 
footwear 
Paton et al, 
2014; 
Paton et al, 
2012 
49,50  




Rocker added to forefoot positioned 









outsole of shoe 
Owings et al, 
200848 
Flexible shoe  Rocker angle  20°, located at 65% of the 
sole length as measured from the heel  
Rocker to outer 




rocker designs  
12 variations in apex angle (relative to 
metatarsal break), apex position 
(normalised to shoe length), rocker angle 
EVA and 5mm 
folex rocker 
addition to the 
outsole of a 
standard shoe 
(Duna, Italy)  




Eight variations in rocker angle (15° or 
20°) and apex position (52, 57, 62 and 





1st and- 5th 
Fernandez et 
al, 201334  




Rocker feature prescribed when 
increased vertical pressure in push-off 
stage of walking gait (hallux rigidus, 
functional limitus, 1st ray amputation or 
63 
 







external sole of 
shoe 
digit amputation) assessed by barefoot 









Rocker sole addition comprised of 11mm 
height, 29mm thickness at the heel, 
16mm at the front end and 24mm at the 
maximum of the rocker curve. The rocker 
started to curve up 83mm from the front 
end at the medial side and 87mm at the 
lateral side 
Anterior wedge 
rocker added to 
insole 








Rocker modification of dense closed cell 
foam applied to the insole proximal to 














Bus et al, 
201126  




Pressure informed modification of adding 
earlier or more significant rocker or roller 
either in shoe or outside shoe 
Semi-rigid outer 
sole or stiff 
rocker bottom 
Tang et al, 
201438  
Used in both 
intervention 














Variations of  rocking axis position (60%, 
61.5%, 63%, 65%, 67.5%) and rocking 












Generalised construction with no 
specifications reported 



























Off the shelf footwear  
Diabetic footwear 
(County Orthopaedic 
Footwear Ltd, UK) 
Paton et al, 
2014; 
Paton et al, 
2012 
49,50 
Used in both 
intervention and 
control groups 
Standardised footwear with more 
depth and width 
Extra depth or DX2 




Used in both 
intervention and 
control groups 
Standardised footwear but could 
be adjusted at fitting to include 
stretching  
 
Extra depth footwear 
(Dr Comfort, DJO, UK) 
Wrobel et al, 
2014 65 





Extra depth footwear 
Sir Super Depth (p.w. 
Minor, Batavia, NY) 55 
Durometer, 18 iron. 
Albert  & 
Rinoie 
199420  
Used in both 
intervention and 
control groups 
Not disclosed if patient specific 
Extra depth Rizzo et al., 
201256 
Standard care Semi-orthopaedic footwear on 
market with extra depth to fit 
Custom made insoles. Not clear if 
patient specific. 




Reiber et al., 
1997; 
Reiber et al., 
200254,55  
Used in both 
intervention and 
control groups 
Prototype footwear Extra width 
and height to toe box, increased 
depth to length of shoe. Not clear 
if patient specific. 
Extra depth, width 
and height(Podartis 




et al, 2019 70 
Used in both 
intervention and 
control groups 
Therapeutic shoes with high toe 
box, enough width to 
accommodate toe deformities, 




Birke et al, 
199924  
Used in all 
interventions 










With and without 
insoles 
Advanced orthopaedic footwear 
prescribed according to shoe size 
Extra depth (Finn 
Comfort, Germany). 
Kastenbauer 
et al, 199841 
Oxford style shoes Standardised shoe. Unsure if 
patient specific 
Standard diabetic 
shoes (Dr. Foot 
Technology Co, 
Taiwan) 
Lin et al, 
201343 
Used in all 
interventions 
Xtra depth leather shoes  
Extra depth Telfer et al, 
201768 
Used in all 
interventions 
Only prescribed for use in trial 
runs 
Suitable depth Raspovic et 
al, 200053 
Used in all 
interventions 
Footwear modified to be of 
‘suitable’ depth, but no 
specifications reported. 
Extra deep diabetic 
shoes (Dr Kong 
Footcare Ltd. Taiwan) 
Tsung et al, 
200460 
Used by all 
participants 
Shoe selected to size, according to 
Tovey’s principles. The first 
metatarsophalangeal joint should 
be accommodated in the widest 
part of the shoe and the length 
should allow 1-1.25cm between 
the end of the shoe and the 
longest toe 





Hsi et al, 
200239 
Patients’ own shoes Standardised diabetic footwear  
Extra depth or fully 
customised footwear 
Arts et al, 
2015 
Arts et al, 
201221,22  
Used by all 
participants 
Either ‘Extra-depth’ off-the-shelf 
footwear or custom footwear 
made from last derived  plaster 
cast of foot 
67 
 
Extra depth footwear Fernandez et 
al, 201334  
Used by all 
participants 
Prescribed footwear according to 
length and width of foot, using 
Dahmen’s algorithm. 
Extra depth shoes Uccioli et al, 
199561  
Ordinary shoes Footwear designed according to 
Towey guidelines with super 
depth to fit insoles and toe 
deformities. Not clear if patient 
specific.  
Extra width and depth Scherer 
197558 
Used by all 
participants 
Manufactured according to shoe-
size, foot width and length. 
Bespoke to patient. 
Extra depth protective 
shoes(Thanner, 
Germany)  with deep 
soft uppers and no 





Used by all 
participants 
Protective shoe manufactured 
according to Tovey’s model. 
Unsure if patient specific 
Customised footwear 
or extra depth 
Bus et al, 
201126 
Used by all 
participants 
Participants received either ‘Extra-
depth’ off-the-shelf footwear or 
custom footwear made from last 








soled Oxford style 
shoe (model 7143-A, 
Vab der Hammen B.V. 
Waalwijk, the 
Netherlands), Xtra 
depth Oxford shoe 
(model 3116, Bimakon 
Hederland BV, 
Drunen, NL), Xtra-
depth Diabetic shoe 
(Nimco Orthropedics, 
Shoes fabricated by orthotist 
68 
 




Berg en Dal, the 
Netherlands)  
Retail footwear  
Running shoes (New 
Balance trainers  460, 
US) with 
accommodative 
padding added into 
insole, width sizing 
and smooth outsole 




Used by all 
participants 
Retail-footwear  not patient 
specific 
Extra width and depth 
running shoes (SAS, 
San Antonio, TX, US or 




Used by all 
participants  




















Metatarsal pad or 
metatarsal bar 
 
Bus et al, 
2011 Bus et 
al, 2004 26,27 
n/a Option of use being incorporated into Total 
Contact Insole chosen by orthopaedic shoe-
maker to reduce Peak Pressure in Regions Of 
Interest based on PP data, tracings and static 
footprints in conjunction with other 
modifications   
Metatarsal pad or 
metatarsal bar 
 
Arts et al, 
2015 
Arts et al, 
2012 
21,22  
n/a No clear description of position, size, material, 
shape of pad or bar. Chosen as modifications by 
shoe technicians and repositioned to reduce PP 
in ROI >200kPa. Used in conjunction with arch 







n/a No clear description of position, size, material, 
shape of pad or bar. Option of being 
incorporated into insole prescription for sub-
metatarsal offloading Decision to use based on 
opinion of orthotist 
Metatarsal pad  
 
Hastings et al, 
2007; Lott et 
al, 2007; 
Mueller et al, 
2006 37,45,47  
 
Three sizes of 
metatarsal pad 
made of cork, 
shore value 
55°, selected 




Metatarsal pad applied to Total contact insole 
with adhesive backing. Orthotist/pedorthotist 
drew line to determine metatarsal head location 




Rizzo et al, 
201256 
 
n/a No clear description of position, size, material or 
shape of bar. Used in conjunction with a medial 
arch support. Used based on an individualised 
strategy based on consensus of three clinicians 




2nd to 4th MTPJ 
Mohamed et 
al, 2004 46 
 
n/a No clear description of size, material or shape of 
bar.  Added to six of 16 insoles after one month 
of use due to excessive wear or bottoming out in 
opinion of orthotist. 
Metatarsal bar 
 
Tang et al, 
201438  
n/a No clear description of material or shape of bar. 
Standardised bar, fitted proximal to the 2nd to 4th 
metatarsal heads within the CMI and 
prefabricated insoles. Adjustments including 
raising or lowering bar height, but no 
specifications or rationale given. 
Metatarsal bar 
 
Owings et al, 
200848 
 
n/a No clear description of size, material or shape of 
bar. Created within Total Contact Insole from 
automated design algorithm which identified 




et al, 200736 
 
n/a 11mm high foam rubber (Shore A 28) dome, 
positioned 5mm behind the 2nd to 4th metatarsal 
heads on the insole. Positioned from dynamic 





al, 201334  
n/a No clear description of size, material or shape of 
bar. Used when elevated pressure over static 





Telfer et al, 
201768 
n/a No clear description of position, size, material or 
shape of bar or pads. Manufacturer could use 
this if felt appropriate as per standard practice 
for CMI; met bar increased in height to reduce 
peak pressure in cad cam design 
Metatarsal pad or 
bar 
Parker et al, 
2019 73 
n/a Used on two of the insoles at discretion of 
orthotist based on static pressure footprints. No 
clear description of position, size, material or 
shape of bar or pads 
Metatarsal bar Martinez-
Santos et al, 
2019 71  
n/a Distal location and shape defined where plantar 
pressure was 77% of the peak pressure. Used in 







n/a Located at widest part of forefoot with material 
removed from insole and replaced by softer 
material into insole at metatarsal 
PP=peak pressure; ROI=regions of interest; MTPJ=metatarsal phalangeal joint; n/a not applicable 
 
 
Electronic supplementary material 7 -  cut outs or aperture modifications 




Arts et al, 2015 
Arts et al, 2012 
21,22  
 
n/a Removal of material at high pressure areas 
identified by pressure data, tracings and 





Bus et al, 201126 n/a Removal of material to reduce peak 
pressure at regions of interest identified 





 Bus et al, 
200427 
 
n/a Removal of material at areas of high 
pressure identified by pressure data, 





Waajiman et al, 
201264 
 
n/a 33% of insoles modified by removal of 
material at ROI identified by PP in-shoe 
system 
 
Cut out  Lopez-Moral et 
al, 2019 70 
n/a Cut out positioned at the previously 
ulcerated metatarsal head 
Fenestrations 
 




n/a 6mm poron plug embedded in 
fenestrations for areas of high pressure 
and bony prominence and joints which 





 Lin et al, 201343 Pre-plug 
removal 
Plugs 1cm x 1cm removed in forefoot area 






Owings et al, 
2008 48 
n/a 3mm deep aperture for regions of 
excessive pressure >1000kPa 
 
Aperture or u 
shaped rubber 
Raspovic et al, 
200053 




Telfer et al, 
201768 
n/a Used to reduce regional MPP to under 
200kPa informed by finite element 
modelling 




Parker et al, 
2019 73 
n/a Utilised on seven of the insoles at 














Shore A), EVA 






Distal border of void placed distal to area 
of peak pressure and used in conjunction 
with metatarsal bar;  








Electronic supplementary material 8 - Casting technique 
Casting technique Studies n=23 Comparator Comments 
Plaster of Paris 
 
Albert  & 
Rinoie 
199420  
n/a  No technique disclosed  
Plaster of Paris 
 
Burns et al, 
200925 
n/a  Neutral suspension 
technique 
Plaster of Paris 
 
Tang et al, 
201438  
n/a  Positive mould based on 
negative cast; patient 
prone positioned 
Plaster of Paris or 
foam box 
Arts et al, 
2015 
Arts et al, 
201221,22  
n/a Positive cast with 
additional modifications 
informed by shoe 
technician 
Plaster of Paris 
 
Viswanathan 
et al, 200463 
n/a Positive mould, no other 
specifications 
Plaster of Paris Coagiuri et 
al, 199531 
n/a STJ neutral, mid-tarsal 
maximally pronated. 




n/a No technique disclosed 
Foam box  Rizzo et al, 
201256 
n/a Feet in neutral, knees 
90°. Used with 
information from static 
footprint  
Foam box Nouman et 
al, 201766 
n/a Sub talar joint in neutral, 
knees 90°. Modifications 
informed by information 
from static footprint 
Foam box Paton et al, 
2014; 
Paton et al, 
2012 
49,50  
n/a Cad-Cam technique to 
mill Custom Made Insole 
74 
 
Foam box Hastings et 
al, 200737 
n/a Design and modifications 
based on clinical decision 
by orthotists  
Foam box Owings et al, 
200848 
n/a No technique disclosed  
Foam box Lott et al, 
200745,47  
n/a No technique disclosed 
Foam box Nouman et 
al, 2019 72 
n/a Cast obtained by a 
qualified orthotist; no 
other specifications 
disclosed 




(standing on casting foot 
only) compared with 
semi-weight-bearing 
(standing only) with non-
weight-bearing (sitting, 
ankle neutral, knee 90°) 
 
Cad-cam Bus et al, 
2011 Bus et 
al, 200426,27 
n/a Based on plantar 
pressure data, tracings 
and footprint 
Laser digitizer Reiber et al, 
1997; 





image of contours of foot 
uploaded into software 
which creates 3D image 
of foot 
Digital AMFIT (AMFIT 
Incorporated, 
Vancouver, WA, USA) 
system 
Wrobel et 
al, 2014 65 
Standard insoles Image of foot digitized 
and used to manufacture 
insoles and Dynamic Foot 
Orthoses 
‘Cast’  Uccioli et al, 
199561  
n/a No technique disclosed 
Foam box, cad cam, 
finite element 
Telfer et al, 
201768 
Shape date and milling 
produced insole 
Individualised for each 
patient with different 
75 
 
techniques compared to 
inform manufacturing 
processes 
Foam box and 
weightbearing digital 
foot scan 
Parker et al, 
2019 73 
Flat 3mm poron insole Foam box devices 
manufactured with 
plaster impression, heat 
moulded to cast and 
hand finished by blinded 
technicians. Digital scan 
from barefoot standing 
and modified by orthotist 
based on static pressure 
data. 
n/a not applicable 
 




Pedar-X  (Novel, GmbH, 
Munich, Germany) in-
shoe system  
 
Bus et al, 
2011; 
Waajiman 
et al, 2012; 
Waajiman 
et al, 2012 
21,26,64 
 
Used for all 
participants 
Identify regions of 
interest>200kPa in the midfoot 
or forefoot; modified insoles 
using a set algorithm with up to 
three rounds of modifications to 
achieve regions of interest 
optimisation (25% below MPP 
or <200kPa).  
Pressure platform (Novel 
EMED-SF, USA) for 
barefoot pressures 
Bus et al, 
200427 
 
Standard insole Used barefoot plantar pressure 
data to inform custom made 
insole 
Pedar X  (Novel, GmbH, 
Munich, Germany) in-
shoe system   
Lin et al, 
201343 
 
Used for all 
participants 
Plugs were removed from the 
insole at the Region of 












Used for all 
participants 
Used barefoot plantar pressure 
data and radiophotopodogram 
findings to inform for selective 
offloading using insoles 
Static footprint taken 
with the patient standing 
barefoot  
Rizzo et al, 
201256 
 
Standard treatment Used in conjunction with foam 
box impression of feet to 
identify problem areas requiring 
attention by three professionals 
in discussion. 
Pedar (Novel, GmbH, 
Munich, Germany) in-




al, 199754  
Standard insole Data is used to create a 3D 
image template, from which the 
custom insole is milled from 
cork blanks, with modifications 
identified by physical 
landmarks, foot exam and foot 
pathology 
EMED  (Novel, GmbH, 
Munich, Germany) 
platform for barefoot 
dynamic testing 
Owings et 
al, 2008 48 
 
Insoles not designed 
by pressure data 
Data used in conjunction with 
foam box cast and computer 
display to create insole with 
metatarsal bar and 3mm deep 
area aperture in areas 
>1000kPa;  
Dynamic pressure sheet 
footprint to determine 
the locations of the 
metatarsals to position 
the metatarsal domes. 
Guldemond 










Static pressure collected 
with platform (Emed 




al, 2019 71 
Used for all 
participants 
Used in conjunction with 3D 
foot shape captured by scanner 
(Inescop, Spain) 
n/a not applicable 
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Electronic supplementary material 10 – materials of insole and footwear 
Materials Studies (n=37) Comparator Comments 
TL-2100 graphite with Naugahyde 
top cover (P.W. Minor and Sons, 
Batavia, NY) 
Albert  & 
Rinoie 199420  
n/a Dual density and 
rigid device aimed 
at placing 
abnormal foot in 
an optimal 
functioning 
position; used only 
in pronated foot 
posture 
participants 
10mm thick rubber-foam 
(Zellkautschuk, Berkemann, 
Hamburg, Federal Republic 
Germany)  and other plastics (PPT 
and Platazote; Schein, Remscheid, 
Federal Republic Germany) insole; 
soft leather shoe 
Chantelau et 
al, 199029 







Shoes made from soft leather upper, 
outersole of microcellular rubber, 
with 5mm folex for rocker (Duna, 
Falconara Marittima, Italy) 
Chapman et al, 
201330 
n/a Materials selected 
to prevent flexion 
of shoe 
Rohadur thermal plastic (Ozthotics, 
Randwick, NSW, Australia 
Colagiuri et al, 
199531 
n/a Material choice for 
‘control’ of foot 
function to reduce 
plantar foot 
pressures 
Thor Lo hosiery (Thor-Lo, Statesville, 
NC) 
Donaghue et 
al, 1996 33 
n/a Unknown materials 
of shoes or hosiery 
For static pressures: heat moulded 
laminar EVA insole (25°-60° Shore) 
base with a 3mm PPT layer  
Fernandez et 
al, 201334 






heat moulded laminar EVA (25°-60° 
Shore) For pressure and boney 
prominence: EVA insole (25° -33° 
Shore) with maximum thickness of 
1.5-2cms with high density EVA (60° 
Shore) bottom layer. 6mm Poron 
used to offload specific areas 




material used in 
areas of bone 
protrusion or 
previous ulcer and 
wound sites. 
Multi-layer orthosis EVA orthosis 
(40°Shore) with poron top cover; 
shoe material made of soft skin 
Lopez-Moral et 
al, 2019 70 
n/a No rationale for 
material choice 
Alipast and plastazote (Voltek, 










Insole 1:thin polypropylene shell 
with Korex, sponge or plasatazote 
top cover;  Insole 2: 45 Shore S EVA 
base with Procell or plastazote top 
cover; Insole 3: 35 Shore A Microcel 
Puff EVA base and a Poron or P-Cell 
top cover 
Owings et al, 
200848 
n/a Dual density 
insoles with 
materials selected 
as commonly used 
in offloading. 
3mm medium density EVA base with 
6mm Poron top cover  
Paton et al, 
2014; 
Paton et al, 
2012 
49,50  




aimed at reducing 
plantar pressure; 
durability also 




Medium density rubber cork inserts, 
1.5mm layer foam backed nylon 
tricot top layer 
 Shoes made of high quality cowhide  
leather with urethane (Meramec 
Group, Sullivan, MO) outersole 
Reiber et al, 
1997; 
Reiber et al, 
200254,55 
Standard study 
insole: closed cell 
polyurethane 
foam  
Dual density insole; 
cork used for little 
set or deformation 
and top cover aims 
for ‘cushioning 
interface between 
foot and insole 
Shoes made of Bottine, soft 
thermformable leather; insoles 
made of PPT (Deer Park NY), 
Duoterm (Mibor, Alcoy, Spain) and 
Alcaform (Zotefoams Plc, Croydon, 
UK) 
Rizzo et al, 
201256 
n/a PPT to relieve local 
pressure, Duoterm 
and Alcaform to 
absorb high 
pressure points 
Natural leather skin upper,  
synthetic rubber sole 
Scherer 197558  n/a No rationale 
provided 
Shoes made of soft thermformable 
leather; Insoles made of Alcapy 
(Deer Park, NY) and Alcaform  
Uccioli et al, 
199561  
n/a Alcapy to relieve 
local high 
pressures and 
Alcaform to absorb 
high pressure 
points 
8mm Polylux, 8mm Combilux, 
2.3mm Memorix, 3mm Remember 
and 0.7mm Calbino topcover 
(Thanner, GmgH, Hochstadt, 
Germany) 
Burns et al, 
200925 






Mesh of materials 
combined; no 
rationale provided 
Diabetiker SY2 modular viscoelastic 
insole of 2.5mm polyvinyl  chloride 
(Kraemer, Remscheid, Germany) 
Hsi & Lai, 2002; 
Hsi et al, 
200439,40 
n/a to act as shock 
absorbers with24  
sensors embedded 
in insole 
Shoe  made from EVA and rubber 
(Softgummi) sole, cloth, rubber foam 




n/a Soft density upper 




Rear part containing 6mm lunasoft, 
42° Shore A hardness; anterior part 
6mm Lunaflex, 20° Shore A 
hardness; covered with 3mm thick 
PPT, 17° Shore A hardness) 
firmer density 











5mm Lunalastick and 8mm Lunasoft 
SL (NORA, Freudenberg, GmbH, 
Weinheim, Germany) top and 
bottom and 1.1mm Rhenoflex 3208 




n/a Higher stiffness 
materials above 
Shore A 60° used 




3mm Shore A 35° EVA in the first 
layer, 2mm Velcro and velvet in the 
second layer and 6mm Shore A 50° 
Poron in the third layer 
Lin et al, 201343 n/a No rationale for 
material choice 
14mm multi-combination insole 
EVA, polyethylene foam, 
elastomere, silicone  
Lobmann et al, 
200144 




required degree of 
hardness 
Custom made insole open cell 
urethane foam hardness 60-80 
(Langer, Inc, Deer Park, NY, USA) 
with the addition of 2mm base and 
0.7mm top cover 
Bus et al, 
200427 
Flat insole 0.95cm 
thick PPT(Langer, 










Multifoam as the top layer, 
Plastazote (Streifeneder ortho 
production GmbH, Emmering, 
Germany) as the second layer and 
microcellular rubber as the final 
stabilising layer 
Nouman et al, 
201766 
n/a No rationale for 
materials given 
5mm thick multifoam (30° Shore A 
hardness), 8mm thick Plastazote (25° 
Shore A Hardness) and 10mm thick 
microcellular rubber (70° Shore A 
hardness)  
Nouman et al, 
2019 72 
Dual density insole 
of 8mm thick 
Plastazote (25° 
Shore A Hardness) 
and 10mm thick 
microcellular 









Rohadur (Ozthotics, Randwick, NSW, 
Australia) device with dual acrylic 
posts added to rearfoot to balance 
foot 
Coagiuri et al, 
199531 
n/a Rigid orthotic  to 
provide functional 
control providing 







Insole made of closed-cell 
polyurethane foam and soft insole 
cover 
Frykberg et al, 
201335 
n/a No rationale 
provided 
Dynamprene (neoprene based, 








insole made up of 
Aimed at shock-
absorbing but not 
specific to patient 
82 
 






1.27cm #2 plastizote (Shore 35°), 
5.0mm thick cross-linked 
polyethelene foam blended with 
EVA insole and Cork (Shore 55°) met-
pad 
Hastings et al, 
2007; Lott et 
al, 2007; 
Mueller et al, 
2006 37,45,47 
n/a No rationale 
provided 
¼” thick Poron 14°Shore Hardness Birke et al, 
199924 
Seven (17°,22°, 
27°, 32°, 40°, 50° 
Shore hardness) 
densities of Poron 




as most popular 
non moulded 
orthosis material 
to reduce pressure 
Insole made of Poron 96 (Rogers 
Corporation, Woodstock, CT)  
Cumming & 
Bayliff 201132 
Insole made of 




One left and one 
right insole of each 




one week duration 
35 durometer EVA base and added 
two non-stick sheets, held with 
elastic binders, between the upper 
pad and lower pad of 3mm thick 45 
durometer EVA. To this a 3mm thick 
20 durometer polyethylene foam 
top was added 
Lavery et al, 
201242 
Standard insole 
made of 35 
durometer EVA 
base, lower pad of 
3mm thick 45 
durometer EVA. 










top was added 
4mm cushioned properties  Perry et al, 
199551 
n/a Insole within Nike 




Padded insoles Soulier 1986 59 n/a Insole within New 
Balance 460 
running shoe; no 
description of 
materials 
Insole made of polyurethane, EVA, 
or 10mm microcellular rubber insole 
and 8mm rubber sole, 5mm 
polyurethane foam insole, 5mm 
MCR midsole and 10mm EVA outer 
sole or10mm EVA as outer sole, 




Insole of hard 
leather board,  
Materials selected 
due to being 
lightweight, shock 
absorbent, flexible 
and highly durable 
Insoles made of Rubbatex neoprene 
rubber top cover with 4-way stretch 
darlex (Richardson Products 
Incorporated, Frankfort, IL, USA), 
silicone layer that was based on firm 
density EVA base lined with ballistic 
nylon 
Wrobel et al, 
2014 65 
Standard Insoles 
made of firm 
density plastazote 
and PPT bi-lam 
(American Plastics 





and reduce sliding 
friction 
Custom made insole of Nora 
Lunasoft A50° hardness 
(Freudenberg, Germany) and 3mm 
Poron top cover 3mm thickness  
Tsung et al, 
200460  
 





3mm Poron top 







Shoes mainly of leather with rubber 
outsole; insole of Mouldable cork or 
multifoam base, open or closed cell 
material top cover 
Bus et al, 2011; 
Waajiman et 
al, 201226,64 
n/a Materials selected 
as they are 
commonly used in 
practice 
EVA (A35°) with laminated fabric PPT 
top cover 
Ulbrecht et al, 
201462 
n/a No rationale 
provided 
Shoes made of  stiffened rubber 
and/or polyethylene reinforced 
outer sole with insole of Rhenoflex 
thermoplastic (Ludwigshafen-am-
Rhein, Germany) with multifoam or 
cork base finished with plastazote 
(Zotefoams plc, Croydon, UK), 
leather or PPT (Langer Inc, Deer 
pArk, Ny, USA) top cover 
Arts et al, 2015 
Arts et al, 
201221,22  





Insoles made of EVA Shore hardness 
35° or 55°) 
Tang et al, 
201438 
Prefabricated 






to assess ability to 
reduce kinetic 
variables  
Rubber pad on unknown base for 
most of insoles; one insole of 
polyproprolene shell and one insole 
EVA shell 
Raspovic et al, 
200053 
n/a No rationale 
provided 
EVA insole with 3mm PPT cover; 








soled shoe; soft 
leather shoe with 
insole made of 
10mm EVA with 







3mm PPT top 
cover & 3mm 
rocker; soft 
leather shoe with 
insole made of 
10mm EVA with 
3mm PPT top 
cover & 3mm 
rocker 
6mm Medium density EVA rearfoot 
(30-40 Shore A), 6mm poron (20 
Shore A) at forefoot with topcover 
of leather 
Parker et al, 
2019 73 




Insole made of medium density EVA 
(50° Shore A) with variety of 
modifications using void conditions 
(EVA 20° Shore A, Poron 20° Shore 
A) and 
Martinez-
Santos et al, 
2019 71 
Flat insole made of 




Prefabricated insole (10mm EVA 
base Shore A35, upper layer 6mm 
EVA Shore A 25) EVA and 1mm EVA 
shore A 25 top cover 









shell of insole 
Legend: EVA-Ethyl-Vinyl Acetate, PPT – Professional Protective Technology, n/a not applicable 
 
 
 
 
 
 
86 
 
 
 
